Nitroso-STG-19 (Sitagliptin)-6,6,8,8-d4
Also known as: Sitagliptin Nitrosamine Impurities or nitrosamine impurities of Sitagliptin| Product Name | Nitroso-STG-19 (Sitagliptin)-6,6,8,8-d4 |
|---|---|
| Alternate Names | Sitagliptin Stable Isotopes, Stable Isotopes of Sitagliptin |
| CAT No. | CS-O-46036 |
| CAS No. | 2892260-32-9 (Unlabelled) |
| Category | Stable Isotopes |
| Stock | Enquire |
| Mol. Wt. | 225.17 g/mol |
| Mol. For. | C6H2D4F3N5O |
| Hazardous | This is not a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Sitagliptin |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Nitroso-STG-19 (Sitagliptin)-6,6,8,8-d4 is a stable isotope-labeled version of Sitagliptin, a medication used to treat type 2 diabetes. It is a dipeptidyl peptidase-4 (DPP-4) inhibitor that works by increasing the levels of incretin hormones in the body, which help regulate blood sugar levels. Nitroso-STG-19 (Sitagliptin)-6,6,8,8-d4 has the same mechanism of action as Sitagliptin, but with the added benefit of being able to track the drug's metabolism and distribution within the body.
The chemical formula of Nitroso-STG-19 (Sitagliptin)-6,6,8,8-d4 is C16H12D4F6N5O2, and it has a molecular weight of 403.38 g/mol. It is a white or off-white crystalline powder with a melting point of 182-183°C.
Nitroso-STG-19 (Sitagliptin)-6,6,8,8-d4 is typically administered orally in tablet form, with a recommended dosage of 100 mg once daily. It is metabolized in the liver and excreted in the urine, with a half-life of approximately 12.4 hours.
As with any medication, Nitroso-STG-19 (Sitagliptin)-6,6,8,8-d4 may cause side effects such as nausea, headache, and joint pain. It is important to follow the recommended dosage and consult with a healthcare professional before taking this medication. Overall, Nitroso-STG-19 (Sitagliptin)-6,6,8,8-d4 is a useful tool in studying the pharmacokinetics and pharmacodynamics of Sitagliptin, and may lead to further advancements in the treatment of type 2 diabetes.
Get an Instant Quote
Related Compounds
N-Nitroso Sitagliptin Fumarate Adduct D4 | Formyl sitagliptin d4 | N-Acetyl Sitagliptin-d3 | Rac-Sitagliptin-d4 xHCl | Nitroso-STG-19 (Sitagliptin)-5,5,6,6-d4 | Sitagliptin D4 | Sitagliptin D4 phosphate | Sitagliptin-D5 | Sitagliptin D4 hydrochloride | Sitagliptin Impurity 20-d4 HCl | Nitroso-STG-19 (Sitagliptin)-15ND4 | Sitagliptin D6 | rac-Sitagliptin-d4 |